Heart Rhythm
Volume 6, Issue 6 , Pages 752-759 , June 2009

Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery

  • Christopher A. Collura, MD

      Affiliations

    • Department of Pediatrics/Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota
    • ,
  • Jonathan N. Johnson, MD

      Affiliations

    • Department of Pediatrics/Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota
    • ,
  • Christopher Moir, MD

      Affiliations

    • Department of Surgery/Division of Pediatric Surgery, Mayo Clinic, Rochester, Minnesota
    • ,
  • Michael J. Ackerman, MD, PhD

      Affiliations

    • Department of Pediatrics/Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota
    • Department of Medicine/Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
    • Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota
    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Michael J. Ackerman, Long QT Syndrome Clinic and the Mayo Clinic Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Guggenheim 501, 200 First Street SW, Rochester, Minnesota 55905

References 

  1. Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J. 1957;54:59–68
  2. Stramba-Badiale M, Crotti L, Goulene K, et al. Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. Circulation. 2007;116:II–377
  3. Ackerman MJ. Cardiac channelopathies: it's in the genes. Nat Med. 2004;10:463–464
  4. Chen L, Marquardt ML, Tester DJ, Sampson KJ, Ackerman MJ, Kass RS. Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc Natl Acad Sci U S A. 2007;104:20990–20995
  5. Medeiros-Domingo A, Kaku T, Tester DJ, et al. SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome. Circulation. 2007;116:134–142
  6. Ueda K, Valdivia C, Medeiros-Domingo A, et al. Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex. Proc Natl Acad Sci U S A. 2008;105:9355–9360
  7. Tester DJ, Will ML, Haglund CM, Ackerman MJ. Effect of clinical phenotype on yield of long QT syndrome genetic testing. J Am Coll Cardiol. 2006;47:764–768
  8. Reid DS, Tynan M, Braidwood L, Fitzgerald GR. Bidirectional tachycardia in a child (A study using His bundle electrography). Br Heart J. 1975;37:339–344
  9. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69–74
  10. Eldar M, Pras E, Lahat H. A missense mutation in the CASQ2 gene is associated with autosomal-recessive catecholamine-induced polymorphic ventricular tachycardia. Trends Cardiovasc Med. 2003;13:148–151
  11. Lahat H, Eldar M, Levy-Nissenbaum E, et al. Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation. 2001;103:2822–2827
  12. Priori SG, Napolitano C, Tiso N, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001;103:196–200
  13. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children (A 7-year follow-up of 21 patients). Circulation. 1995;91:1512–1519
  14. Napolitano C, Priori SG. Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2007;4:675–678
  15. Moss AJ, Zareba W, Hall WJ, et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation. 2000;101:616–623
  16. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008;52:1111–1121
  17. Moss AJ, McDonald J. Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome. N Engl J Med. 1971;285:903–904
  18. Schwartz PJ, Snebold NG, Brown AM. Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am J Cardiol. 1976;37:1034–1040
  19. Schwartz PJ, Stone HL, Brown AM. Effects of unilateral stellate ganglion blockade on the arrhythmias associated with coronary occlusion. Am Heart J. 1976;92:589–599
  20. Schwartz PJ, Stone HL. Left stellectomy in the prevention of ventricular fibrillation caused by acute myocardial ischemia in conscious dogs with anterior myocardial infarction. Circulation. 1980;62:1256–1265
  21. Schwartz PJ, Stone HL. Effects of unilateral stellectomy upon cardiac performance during exercise in dogs. Circ Res. 1979;44:637–645
  22. Schwartz PJ, Priori SG, Cerrone M, et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004;109:1826–1833
  23. Wilde AA, Bhuiyan ZA, Crotti L, et al. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med. 2008;358:2024–2029
  24. Bazett H. An analysis of the time-relations of electrocardiograms. Heart. 1920;7:353–370
  25. Schwartz PJ, Priori SG, Locati EH, et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate (Implications for gene-specific therapy). Circulation. 1995;92:3381–3386
  26. Atallah J, Fynn-Thompson F, Cecchin F, DiBardino DJ, Walsh EP, Berul CI. Video-assisted thorascopic cardiac denervation: a potential novel therapeutic option for children with intractable ventricular arrhythmias. Ann Thorac Surg. 2008;86:1620–1625
  27. Li J, Liu Y, Yang F, et al. Video-assisted thoracoscopic left cardiac sympathetic denervation: a reliable minimally invasive approach for congenital long-QT syndrome. Ann Thorac Surg. 2008;86:1955–1958
  28. Li J, Wang L, Wang J. Video-assisted thoracoscopic sympathectomy for congenital long QT syndromes. Pacing Clin Electrophysiol. 2003;26:870–873
  29. Schwartz PJ. The rationale and the role of left stellectomy for the prevention of malignant arrhythmias. Ann N Y Acad Sci. 1984;427:199–221
  30. Schwartz PJ, Stone HL. Left stellectomy and denervation supersensitivity in conscious dogs. Am J Cardiol. 1982;49:1185–1190
  31. Weatherford DA, Stephenson JE, Taylor SM, Blackhurst D. Thoracoscopy versus thoracotomy: indications and advantages. Am Surg. 1995;61:83–86
  32. Schwartz PJ, Spazzolini C, Crotti L. All LQT3 patients need an ICD: true or false?. Heart Rhythm. 2009;6:113–120

 Dr. Ackerman's research program was supported by the Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program, the Dr. Scholl Foundation, the CJ Foundation for SIDS, Hannah Wernke Memorial Foundation, an Established Investigator Award from the American Heart Association, and the National Institutes of Health (HD42569).

 Dr. Ackerman is a consultant for PGxHealth, Medtronic, and Pfizer.

PII: S1547-5271(09)00315-4

doi: 10.1016/j.hrthm.2009.03.024

Heart Rhythm
Volume 6, Issue 6 , Pages 752-759 , June 2009

Article Tools

* Image Usage & Resolution